Eduardo Rivera-Mancilla

6PUBLICATIONS
10CO-AUTHORS
Biologically active moleculesFluid-structure interaction and aeroacousticsComputational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)PharmacogenomicsBasic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 07, 2025
Functional crosstalk between the vanilloid and endocannabinoid systems in modulating vascular tone: implications for (neuro)vascular disorder therapy.

Eduardo Rivera-Mancilla, Antoon van den Bogaerdt, A H Jan Danser

|Feb 16, 2025
Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders.

Eduardo Rivera-Mancilla, Usha M Musterd-Bhaggoe, Dennis Schutter

|Feb 24, 2024
Functional Analysis of TRPA1, TRPM3, and TRPV1 Channels in Human Dermal Arteries and Their Role in Vascular Modulation.

Eduardo Rivera-Mancilla, Linda Al-Hassany, Heleen Marynissen

|Jul 14, 2022
Streptozotocin-induced diabetes in rats modifies the role D2 , D3 and D4 dopamine receptors play in cardiac sympathetic inhibition.

Eduardo Rivera-Mancilla, Alain H Altamirano-Espinoza, Guadalupe Manrique-Maldonado

|Feb 19, 2020
The role of purinergic P2Y12 and P2Y13 receptors in ADPβS-induced inhibition of the cardioaccelerator sympathetic drive in pithed rats.

Belinda Villanueva-Castillo, Eduardo Rivera-Mancilla, Kristian Agmund Haanes

|Jul 26, 2019
Activation of Dopamine D3 Receptor Subtypes Inhibits the Neurogenic Systemic Vasodilation Induced by Stimulation of the Perivascular CGRPergic Discharge.

Guadalupe Manrique-Maldonado, Alain H Altamirano-Espinoza, Eduardo Rivera-Mancilla

Pageof 1